David P Hatch

Array ( [id] => 3928631 [patent_doc_number] => 05939074 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-17 [patent_title] => 'Multideterminant peptide antigens' [patent_app_type] => 1 [patent_app_number] => 8/407252 [patent_app_country] => US [patent_app_date] => 1995-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 7713 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/939/05939074.pdf [firstpage_image] =>[orig_patent_app_number] => 407252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3802231 [patent_doc_number] => 05830634 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Peptides derived from a retrovirus of the HIV group and their use' [patent_app_type] => 1 [patent_app_number] => 8/394021 [patent_app_country] => US [patent_app_date] => 1995-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10359 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830634.pdf [firstpage_image] =>[orig_patent_app_number] => 394021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3950312 [patent_doc_number] => 05935579 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-10 [patent_title] => 'AIDS therapy and vaccine' [patent_app_type] => 1 [patent_app_number] => 8/323686 [patent_app_country] => US [patent_app_date] => 1994-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 28810 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/935/05935579.pdf [firstpage_image] =>[orig_patent_app_number] => 323686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3799947 [patent_doc_number] => 05830476 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Active induction or passive immunization of anti-Gp48 antibodies and isolated gp48 protein' [patent_app_type] => 1 [patent_app_number] => 8/306605 [patent_app_country] => US [patent_app_date] => 1994-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 3483 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830476.pdf [firstpage_image] =>[orig_patent_app_number] => 306605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4257989 [patent_doc_number] => 06258607 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-10 [patent_title] => 'Indirect agglutination immunoassay and apparatus therefor' [patent_app_type] => 1 [patent_app_number] => 8/082373 [patent_app_country] => US [patent_app_date] => 1993-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 7334 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/258/06258607.pdf [firstpage_image] =>[orig_patent_app_number] => 082373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4361491 [patent_doc_number] => 06274134 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Human cell adhesion protein AAMP-1 and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/083945 [patent_app_country] => US [patent_app_date] => 1993-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 13243 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274134.pdf [firstpage_image] =>[orig_patent_app_number] => 083945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4159994 [patent_doc_number] => 06156883 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Polyclonal and monoclonal antibodies to Norwalk virus and methods for making them' [patent_app_type] => 1 [patent_app_number] => 8/184885 [patent_app_country] => US [patent_app_date] => 1993-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 8679 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156883.pdf [firstpage_image] =>[orig_patent_app_number] => 184885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4149152 [patent_doc_number] => 06103238 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-15 [patent_title] => 'Selectively deglycosylated human immunodeficiency virus type 1 envelope vaccines' [patent_app_type] => 1 [patent_app_number] => 7/850770 [patent_app_country] => US [patent_app_date] => 1992-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 7313 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/103/06103238.pdf [firstpage_image] =>[orig_patent_app_number] => 850770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3937539 [patent_doc_number] => 05976541 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Potent peptide for stimulation of cytotoxic T lymphocytes specific for the HIV-1 envelope' [patent_app_type] => 1 [patent_app_number] => 7/847311 [patent_app_country] => US [patent_app_date] => 1992-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 13 [patent_no_of_words] => 13561 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/976/05976541.pdf [firstpage_image] =>[orig_patent_app_number] => 847311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4411570 [patent_doc_number] => 06265539 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Prophylaxis and therapy of acquired immunodeficiency syndrome' [patent_app_type] => 1 [patent_app_number] => 7/834923 [patent_app_country] => US [patent_app_date] => 1992-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11815 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265539.pdf [firstpage_image] =>[orig_patent_app_number] => 834923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4207659 [patent_doc_number] => 06077935 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-20 [patent_title] => 'Acquired immune deficiency syndrome (AIDS) viral envelope protein and method of testing for AIDS' [patent_app_type] => 1 [patent_app_number] => 7/811896 [patent_app_country] => US [patent_app_date] => 1991-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 11 [patent_no_of_words] => 10381 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/077/06077935.pdf [firstpage_image] =>[orig_patent_app_number] => 811896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3930641 [patent_doc_number] => 05980900 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Amino acid DNA sequences related to genomic RNA of human immunodeficiency virus (HIV-1)' [patent_app_type] => 1 [patent_app_number] => 7/751059 [patent_app_country] => US [patent_app_date] => 1991-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 26 [patent_no_of_words] => 4130 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/980/05980900.pdf [firstpage_image] =>[orig_patent_app_number] => 751059 [rel_patent_id] =>[rel_patent_doc_number] =>)